UK in­vests $13M+ in 17 bio­phar­ma man­u­fac­tur­ers

The UK is mak­ing a £13 mil­lion in­vest­ment in­to 17 man­u­fac­tur­ers dot­ted through­out the coun­try.

The com­pa­nies do a range of work, in­clud­ing man­u­fac­tur­ing nu­cle­ic acid-based med­i­cines, au­tomat­ing or dig­i­tal­iz­ing man­u­fac­tur­ing ef­forts, or de­vel­op­ing meth­ods around in­tra­cel­lu­lar drug de­liv­ery for vac­cines. The funds come from In­no­vate UK, a pub­lic en­ti­ty sup­port­ing tech­nol­o­gy and sci­ence busi­ness­es.

This in­cludes con­tract man­u­fac­tur­er Rentschler Bio­phar­ma, which plans to im­ple­ment an­a­lyt­i­cal tech­nolo­gies to boost ef­fi­cien­cy in the pro­duc­tion of gene ther­a­pies. Rentschler re­cent­ly built a cell and gene man­u­fac­tur­ing site in Steve­nage.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER